Related Experiment Video
Updated: Sep 8, 2025
05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.8K
[Myocarditis and development of dilated cardiomyopathy]
Christian Bo Poulsen1, Kaspar Rene Nielsen1, Malene Møller Jørgensen1
1Klinisk Immunologisk Afdeling, Aalborg Universitetshospital.
Ugeskrift for Laeger
|June 15, 2022
Summary
Myocardial inflammation, or myocarditis, is a key factor in cardiovascular disease. This review updates clinicians on diagnosing, predicting, and managing inflammatory cardiomyopathy, highlighting its growing importance.
Area of Science:
- Cardiology
- Immunology
- Oncology
Background:
- Inflammation is a recognized contributor to cardiovascular disease (CVD) development and progression.
- Recent advances in oncology (immune checkpoint inhibitors) and the COVID-19 pandemic have renewed focus on the immune system's role in myocardial inflammation (myocarditis).
Purpose of the Study:
- To update clinicians on the current understanding of myocardial inflammation.
- To provide comprehensive information on the diagnostic workup, prognostication, and management of inflammatory cardiomyopathy.
Main Methods:
- This review synthesizes current literature and clinical guidelines.
- Focuses on diagnostic modalities and therapeutic strategies for myocarditis.
Main Results:
- Myocardial inflammation is a critical factor in CVD.
- Diagnostic approaches and prognostic indicators for myocarditis are evolving.
- Current management strategies are based on underlying causes and severity.
Conclusions:
- Myocardial inflammation requires increased clinical attention.
- Up-to-date knowledge on diagnosis, prognosis, and management is essential for effective patient care.
- The interplay between immunology and cardiology is crucial in managing inflammatory cardiomyopathies.
More Related Videos
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
01:21Myocarditis I: Introduction
28
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
28
01:25Cardiomyopathy I: Introduction and Classification
49
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
49
01:27Myocarditis II: Clinical Features and Diagnostic Tests
20
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20
01:14Myocarditis III: Medical Management
15
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
15
01:23Rheumatic Heart Disease I: Introduction
38
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
38